Status:
COMPLETED
Study in Patients With COPD
Lead Sponsor:
Dey
Conditions:
COPD
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
5-70 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug
Eligibility Criteria
Inclusion
- Diagnosis of COPD
- History of cigarette smoking
Exclusion
- Clinical diagnosis of asthma
- Significant pulmonary disease other than COPD
- Other significant major organ disease(s)
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT00215423
End Date
September 1 2005
Last Update
November 11 2010
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Phoenix, Arizona, United States, 85006-2666
2
Research Site
Wheat Ridge, Colorado, United States, 80033
3
Research Site
Hines, Illinois, United States, 60141
4
Research Site
Shawnee Mission, Kansas, United States, 66216